22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehen22.03.24 | Vollzeit | Hennigsdorf | 3B Pharmaceuticals GmbH3B Pharmaceuticals (3BP) is a leading developer of targeted molecular radiopharmaceuticals focusing on cancer indications with high medical need. The focus of our drug development programs is a theragnostic approach using diagnostic imaging to identify patients who are likely responders
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Safety Leader in Hennigsdorf kostenlos abonnieren.